Article · 16 Sep 2026
Conference abstract
Enabling the development and life cycle management of oral poorly soluble drugs using lipid-based drug delivery systems
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Lipid-based systems are widely used in drug development and life cycle management to enhance the solubility and oral bioavailability of poorly soluble drugs (BCS II and IV) with several drug products on the market. Despite the progress, however, a pharmaceutical formulator is often contemplating with a number of questions: a) why to consider lipid-based systems over other approaches? b) When lipid excipients and formulations can be applied based on the physicochemical properties of the drug substance? and c) What specific lipid formulations and dosage forms to use for expeditious proof of concept studies? This presentation will address these questions and guide the pharmaceutical formulator through preformulation, feasibility studies and formulation development work. Characteristics of lipid excipients and formulations along with a biopharmaceutical rationale for their use with poorly soluble drugs will be discussed during the first part of the talk. Specific dosage forms, such as, liquid filled hard and soft gelatin capsules, as well as solid dosage forms (tablets and capsules) incorporating lipids will be addressed during the second part of the presentation and compared against certain desired product development characteristics. Then, case studies with BCS II and IV drugs, marketed and NMEs, will highlight biopharmaceutical benefits using lipid formulations which include, improved pharmacokinetics, promotion of lymphatic absorption and inhibition of intestinal metabolism and efflux pumps. The talk will conclude with lessons learned to date and future perspectives in the field.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmaceutica Analytica Acta.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutica Analytica Acta
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Panayiotis P Constantinides”
